Odyssey Therapeutics Price Chart
Odyssey Therapeutics Volume Chart
Odyssey Therapeutics Market Segments
Regular Trading Hours
-0.04(-0.20%)
| Open | $17.61 |
|---|---|
| Close | $17.58 |
| Low | $17.27 |
| Low Change | -0.34 (-1.93%) |
| High | $17.71 |
| High Change | +0.10 (+0.57%) |
| Range | $0.44 |
| Volume | 13.647K |
| Dollar Volume | $239.85K |
Premarket
-1.57(-8.25%)
| Open | $19.02 |
|---|---|
| Close | $17.45 |
| Low | $17.45 |
| Low Change | -1.57 (-8.25%) |
| High | $19.02 |
| High Change | +0.00 (+0.00%) |
| Range | $1.57 |
| Volume | 300 |
| Dollar Volume | $5.24K |
After Hours Yesterday
*No Trades in Segment
Regular Trading Hours Yesterday
+0.67(+4.05%)
| Open | $16.56 |
|---|---|
| Close | $17.23 |
| Low | $16.41 |
| Low Change | -0.16 (-0.94%) |
| High | $17.72 |
| High Change | +1.16 (+7.00%) |
| Range | $1.32 |
| Volume | 382.959K |
| Dollar Volume | $6.60M |
Premarket Yesterday
+0.21(+1.29%)
| Open | $16.27 |
|---|---|
| Close | $16.48 |
| Low | $16.08 |
| Low Change | -0.19 (-1.17%) |
| High | $16.48 |
| High Change | +0.21 (+1.29%) |
| Range | $0.40 |
| Volume | 950 |
| Dollar Volume | $15.66K |
Odyssey Therapeutics Moving Averages
| 5 Day Moving Average (SMA5) | — |
|---|---|
| 10 Day Moving Average (SMA10) | — |
| 20 Day Moving Average (SMA20) | — |
| 50 Day Moving Average (SMA50) | — |
| 100 Day Moving Average (SMA100) | — |
| 200 Day Moving Average (SMA200) | — |
Odyssey Therapeutics Statistics
| Average Volume (30 Days) | — |
|---|---|
| P/E Ratio (Current) | — |
| EPS (Current) | — |
| Dividend Yield | — |
| Free Cash Flow | — |
| Cash Ratio | — |
| Current Ratio | — |
| Quick Ratio | — |
| Debt to Equity | — |
| Enterprise Value | — |
| EV to EBITDA | — |
| EV to Sales | — |
| Price to Book | — |
| Price to Cash Flow | — |
| Price to Free Cash Flow | — |
| Price to Sales | — |
| Return on Assets | — |
| Return on Equity | — |
Odyssey Therapeutics Stock Splits
There have been no stock splits for Odyssey Therapeutics (ODTX).
Odyssey Therapeutics Dividends
There have been no dividends for Odyssey Therapeutics (ODTX).